Skip to content

Clinical trials

Observational Thromboembolism trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Observational Country / region: France Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20121
20131
20153
20172
20181
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Abbott Medical Devices1
Assistance Publique - Hôpitaux de Paris1
Bayer1
Boston Scientific Corporation1
CHU de Reims1
Central Hospital, Nancy, France1
Centre Hospitalier Sud Francilien1
Diagnostica Stago R&D1
Floralis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism16
Atrial Fibrillation3
Neoplasms3
Stroke2
Thrombosis2
Vascular Diseases2
Venous Thromboembolism2
Venous Thrombosis2
Breast Neoplasms1
Cardiovascular Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.